Singapore, April 3, 2008: Canada-based Generex Biotechnology and Singapore-headquartered biotechnology firm SciGen have entered into a product licensing and distribution agreement for Generex Oral-lyn. Generex Oral-lyn is Generex’s proprietary oral insulin spray product.

 

As per the agreement SciGen will procure governmental approvals for importing, marketing, distribution, and sale of Generex Oral-lyn in China, Hong Kong, Indonesia, South Korea, Malaysia, Philippines, Singapore, Thailand, and Vietnam. Generex will formulate Generex Oral-lyn for SciGen.

 

SciGen is globally developing, manufacturing, and marketing biopharmaceuticals. Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.